Forte Biosciences, Inc. (FBRX)
76.94
+0.02
(+0.03%)
USD |
NASDAQ |
Aug 24, 16:00
76.94
0.00 (0.00%)
After-Hours: 20:00
Forte Biosciences Shareholders Equity (Quarterly) : 183.79M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 183.79M |
| March 31, 2026 | 42.10M |
| December 31, 2025 | 60.99M |
| September 30, 2025 | 84.10M |
| June 30, 2025 | 98.61M |
| March 31, 2025 | 38.43M |
| December 31, 2024 | 52.48M |
| September 30, 2024 | 9.366M |
| June 30, 2024 | 16.96M |
| March 31, 2024 | 28.68M |
| December 31, 2023 | 35.31M |
| September 30, 2023 | 40.41M |
| June 30, 2023 | 24.88M |
| March 31, 2023 | 32.95M |
| December 31, 2022 | 38.82M |
| September 30, 2022 | 42.84M |
| June 30, 2022 | 38.21M |
| March 31, 2022 | 40.05M |
| December 31, 2021 | 41.55M |
| September 30, 2021 | 43.65M |
| June 30, 2021 | 49.91M |
| Date | Value |
|---|---|
| March 31, 2021 | 54.70M |
| December 31, 2020 | 58.98M |
| September 30, 2020 | 20.32M |
| June 30, 2020 | 24.88M |
| March 31, 2020 | 2.082M |
| December 31, 2019 | 5.746M |
| September 30, 2019 | 19.80M |
| June 30, 2019 | 36.49M |
| March 31, 2019 | 44.85M |
| December 31, 2018 | 58.14M |
| September 30, 2018 | 47.67M |
| June 30, 2018 | 46.09M |
| March 31, 2018 | 59.68M |
| December 31, 2017 | 71.08M |
| September 30, 2017 | 80.12M |
| June 30, 2017 | 88.57M |
| March 31, 2017 | -1.508M |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | 31.40M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| argenx SE | -- |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 205.74M |
| Total Liabilities (Quarterly) | 21.95M |
| Current Ratio | 10.01 |